Compare
Bio-Rad Laboratories vs Danaher (BIO vs DHR)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Bio-Rad Laboratories (BIO) returned +23.1% and Danaher (DHR) +8.5%; so far this year the figures are +25.9% and +0.6%.
Danaher is the larger company by market value, about 15.8 times the size of Bio-Rad Laboratories.
On trailing earnings, BIO trades at 10.1 times and DHR at 37.7 times.
Revenue grew +1.4% at BIO and +5.5% at DHR over the last year.
BIO pays no dividend. DHR yields 0.66%.
Data as of the latest close. Not investment advice.
Relative performance
| BIO | DHR | |
|---|---|---|
| Price | $381.57 | $230.25 |
| 1-day | +3.41% | +1.73% |
| YTD | +25.93% | +0.58% |
| 1 year | +23.08% | +8.50% |
| 3 years | +37.50% | +21.18% |
| Market cap | $10.3B | $162.0B |
| P/E | 10.1 | 37.7 |
| P/S | 3.97 | 6.33 |
| P/B | 1.35 | 3.02 |
| Revenue growth | +1.40% | +5.50% |
| EPS growth | — | +26.00% |
| Gross margin % | 51.3 | 58.6 |
| Net margin % | 39.5 | 16.9 |
| ROE % | 13.5 | 8.1 |
| Debt / equity | 0.11 | 0.49 |
| FCF yield % | 3.2 | 3.5 |
| Dividend yield % | — | 0.66 |
| Beta | 0.75 | 0.53 |
| RSI (14) | 56.1 | 53.5 |
| Technical rating |